Behavioral Intervention to Reduce Stress Among Black Gender Minority Women
Launched by EMORY UNIVERSITY · Jun 24, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping Black gender minority women, specifically transgender women, cope with stress and psychological issues that come from facing stigma and discrimination. The researchers are creating a special program that is shaped by the input of community members to address these challenges. They want to see if this program can effectively help reduce feelings of distress and depression among participants.
To be eligible for this study, participants must be at least 18 years old, identify as a woman or transgender feminine, and have been assigned male at birth. They should also be able to read and speak English. It's important to note that individuals currently receiving mental health treatment or living in certain controlled environments cannot participate. If you join the study, you can expect to be part of a supportive community effort aimed at improving mental health and well-being. The trial is currently recruiting participants, and your involvement could contribute to important changes for others in the community.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- • gender is woman/transgender feminine/female
- • assigned male sex at birth
- • speak/read English
- Exclusion Criteria:
- • Enrolled in mental health treatment or a controlled consequential environment (e.g. mental health transitional living environment)
About Emory University
Emory University, a leading research institution located in Atlanta, Georgia, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Emory harnesses the expertise of its renowned faculty and state-of-the-art facilities to conduct cutting-edge research across various fields, including oncology, neurology, and infectious diseases. The university's commitment to ethical research practices and patient safety ensures that all clinical trials are designed to generate valuable data that can lead to significant therapeutic advancements. By fostering partnerships with local hospitals and community organizations, Emory strives to translate research findings into real-world applications, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Patients applied
Trial Officials
Athena DF Sherman, PhD, PHN, RN
Principal Investigator
Emory University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials